Home arrow Products
Inanovate Product Overview

Inanovate's protein biochip systems are split into four categories:

Substrates

Using proprietary nano-scale surface patterning technology, Inanovate has developed the leading surfaces in the world for handling and working with proteins. Inanovate's substrate platform, called the i-Slide™, leverages nano-scale surface structures alongside proprietary surface chemistry, to optimize protein immobilization and function. The i-Slide's performance has been validated to sensitivity levels as low as 0.02 pg/mL with accompanying CV values as low as 2%. These performance breakthroughs position the i-Slide as the world's premier surface for protein micro-array experiments.

  

Clinical Diagnostic Systems

Inanovate is developing a low cost, disposable, diagnostic platform for the early detection and monitoring of cancer at the point of care, called the i-Screen.™ The i-Screen™ is being readied for entry into regulatory approval procedures in early 2009.

Inanovate's clinical diagnostic systems are designed to move the healthcare industry’s focus away from expensive, painful and often ineffective late stage cancer treatment, towards early stage diagnosis and lower impact, lower cost therapies.

Service Offerings

Inanovate has extensive protein arraying capabilities, housing fully automated sample handling systems, multiple state of the art protein arrayers, and multiple array and well based scanning and analysis systems.

Leveraging these facilities and our industry leading protein micro-array expertise, Inanovate offers custom protein printing / arraying services, as well as fully integrated assay development services and support. Please contact our enquiries team for further details.

 

   

Biomarker Screening

Inanovate owns excusive rights to a unique method of biomarker discovery, developed at Harvard Medical School, and based on a unique and proprietary reverse capture assay procedure for the rapid and accurate screening of auto-antibody biomarkers. Inanovate has developed this system into a sophisticated biomarker screening platform called the i-Assay.™

Inanovate's pre-clinical protein research systems offer protein researches more accurate, more reliable, and more cost and time effective tools for studying protein interactions and identifying new biomarkers for diagnostic, therapeutic and prognostic applications. In addition to direct customer interactions, Inanovate is seeking collaborators and strategic partners to help deliver these powerful tools to end users.

 

Contact Inanovate

Inanovate (UK) Ltd
Russell House
Russell Street
Swansea
SA1 4HR

Inanovate, Inc
2 Davis Drive
Suite 13169
Research Triangle Park
N.C. 27709

For sales, business development, or investor enquiries:

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Call:

+1-617-395-4460 (US) 
+44-7766-332237 (UK)